Calamos Advisors’s The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 TMAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$1K 1578
2022
Q3
$1K Buy
+25,000
New +$2K ﹤0.01% 1276

Calamos Advisors's TMAC.WS Position: Q4 2022 in Review

Calamos Advisors sold out of The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (TMAC.WS) in Q4 2022, closing a stake of 25,000 shares — an estimated $1K sold.

Calamos Advisors first reported a position in TMAC.WS in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold TMAC.WS as of Q4 2022.

  • Calamos Advisors reported no remaining The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 25,000 The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $1K.
  • Calamos Advisors first reported a position in The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Calamos Advisors's The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $1K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.